Epigral Limited, a top chemical manufacturer in India, recently reported a significant rise in profit, with Q2 FY25 profits reaching ₹81 crore, marking a 111% increase from last year. Revenue also saw growth, up 32% to ₹632 crore compared to ₹479 crore in Q2 FY24.
To meet growing demand, Epigral plans to expand its production of CPVC resin and Epichlorohydrin (ECH) at its Dahej facility in Gujarat. The CPVC facility will reach 1,50,000 tonnes per annum (TPA), making it the largest of its kind globally, while ECH production will reach 1,00,000 TPA, making it the largest in India.
Also read | GAIL and VERBIO India to Develop Biogas Projects Using Farm Waste
This expansion aligns with India’s “Make in India” and “Atmanirbhar Bharat” initiatives, helping the nation become more self-sufficient in essential chemicals. Additionally, Epigral will invest in sustainable practices with Pure.rBrine™ technology, which will reduce waste and greenhouse gas emissions.
Epigral’s Chairman, Maulik Patel, noted that the expansions will support demand growth and enhance shareholder value by H1 FY27.
